Gilead Sciences Announces Promotion of Alessandro Riva to Executive Vice President, Oncology Therapeutics
FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) announced today the promotion of Alessandro Riva, MD, to Executive Vice President, Oncology Therapeutics, with responsibility...